Rubicon Research Overview

  • Founded

  • 1999

Founded
  • Status

  • Private

  • Employees

  • 493

Employees
  • Latest Deal Type

  • Buyout/​LBO

  • Financing Rounds

  • 3

  • Investments

  • 2

Rubicon Research General Information

Description

Manufacturer of generic drugs and nonprescription medicine intended to serve the healthcare industry. The company specializes in developing products across a range of therapeutic categories by leveraging its proprietary technologies and specialized formulation development skills for bioavailability enhancement, gastric retention, taste masking and customizing the release profile, enabling clients to achieve unmet medical needs and enhancing consumer benefits.

Contact Information

Website
www.rubicon.co.in
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Road No. 33
  • MedOne House, Plot No. B-75, Wagle Estate
  • Thane, 400604
  • India
+91 022 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rubicon Research Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rubicon Research‘s full profile, request access.

Request a free trial

Rubicon Research Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of generic drugs and nonprescription medicine intended to serve the healthcare industry. The company specia
Drug Discovery
Thane, India
493 As of 2023
0000 0000-00-00
000000000000

000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
000000000000000
Mumbai, India
0000 0000-00-00
0000000 0000

000000

g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut en
000000000000000
Hyderabad, India
000 As of 0000
0000 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rubicon Research Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Megafine Pharma Failed Transaction (PE) Mumbai, India 0000000 0000
0000000 0000000000 Private Equity-Backed Hyderabad, India 000 000000000000
You’re viewing 2 of 2 competitors. Get the full list »

Rubicon Research Patents

  • 87

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 13

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Rubicon Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220071909-A1 Modified release formulations of levodopa Pending 26-Aug-2020 0000000000 0
US-20200268653-A1 Gastroretentive formulations Active 25-Feb-2019 000000000
US-11147767-B2 Gastroretentive formulations Active 25-Feb-2019 000000000 0
US-20210121398-A1 Gastroretentive formulations Pending 25-Feb-2019 0000000000 0
US-20210228488-A1 Extended release compositions and process for preparation Pending 27-Apr-2018 A61K9/2027
To view Rubicon Research’s complete patent history, request access »

Rubicon Research Executive Team (8)

Name Title Board Seat Contact Info
Parag Sancheti Chief Executive Officer & Board Member
Nitin Jajodia Chief Financial Officer
Pratibha Pilgaonkar Co-Founder, Managing Director & Board Member
L Rao Chief Scientific Officer
Sudhir Pilgaonkar Founder & Chief Commercial Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Rubicon Research Board Members (7)

Name Representing Role Since
00000 00000000 Rubicon Research Chief Executive Officer & Board Member 000 0000
00000000 000000000 Rubicon Research Co-Founder, Managing Director & Board Member 000 0000
0000000 0000 General Atlantic Board Member 000 0000
00000000 0000000 General Atlantic Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Rubicon Research Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rubicon Research Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rubicon Research‘s full profile, request access.

Request a free trial

Rubicon Research Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 09-Jul-2021 0000000000 Pharmaceuticals 00000 000
ImpoPharma 07-Jan-2020 Buyout/LBO Drug Discovery 00000 000
To view Rubicon Research’s complete investments history, request access »